{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:34:10Z","timestamp":1788690850753,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,21]]},"DOI":"10.1093\/ibd\/izy249","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T06:59:34Z","timestamp":1533020374000},"page":"532-540","source":"Crossref","is-referenced-by-count":20,"title":["Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?"],"prefix":"10.1093","volume":"25","author":[{"given":"Zoann","family":"Nugent","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Manitoba, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, Manitoba, Canada"},{"name":"Cancer Care Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Manitoba, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, Manitoba, Canada"},{"name":"Cancer Care Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Targownik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Manitoba, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Manitoba, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"key\n\t\t\t\t2019022112502880300_CIT0001"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0002"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0003","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0004","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/ajg.2009.322","article-title":"Adverse events associated with common therapy regimens for moderate-to-severe Crohn\u2019s disease","volume":"104","author":"Marehbian","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0007","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2013.1099","article-title":"Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster","volume":"309","author":"Winthrop","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0008","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/oxfordjournals.aje.a009735","article-title":"Epidemiology of Crohn\u2019s disease and ulcerative colitis in a central Canadian province: a population-based study","volume":"149","author":"Bernstein","year":"1999","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0009","volume-title":"Composite Measures\/Indices of Health and Health System Performance","author":"Metge","year":"2009"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/AJP.0b013e318065b6c9","article-title":"The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults","volume":"23","author":"Schmader","year":"2007","journal-title":"Clin J Pain"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0011","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0012","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","article-title":"Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake","volume":"9","author":"Malhi","year":"2015","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0014","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1186\/1471-2458-14-1098","article-title":"Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0015","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2018.02.021","article-title":"Effectiveness of herpes zoster vaccination in an older United Kingdom population","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0016","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1016\/j.vaccine.2013.07.053","article-title":"Trends and disparity in zoster vaccine uptake in a managed care population","volume":"31","author":"Hechter","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0017","volume-title":"Manitoba Immunization Study","author":"Hilderman","year":"2011"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0018","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0019","doi-asserted-by":"crossref","first-page":"ofw205","DOI":"10.1093\/ofid\/ofw205","article-title":"Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and\/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis","volume":"3","author":"Marra","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0020","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/MIB.0000000000000902","article-title":"Management and prevention of herpes zoster in the immunocompromised inflammatory bowel disease patient: a clinical quandary","volume":"22","author":"C\u00f4t\u00e9-Daigneault","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0021","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000743","article-title":"Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression","volume":"22","author":"Wasan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0022","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/apt.14257","article-title":"Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications","volume":"46","author":"Khan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0023","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izx115","article-title":"The severity of herpes zoster in inflammatory bowel disease patients treated with anti-TNF agents","author":"Khan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.12.052","article-title":"Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study","author":"Khan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028018758431","article-title":"The new adjuvanted recombinant herpes zoster vaccine","volume":"52","author":"James","year":"2018","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0026","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijcp.12508","article-title":"Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study","volume":"69","author":"Tsai","year":"2015","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t2019022112502880300_CIT0027","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/3\/532\/27940938\/izy249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T21:12:27Z","timestamp":1550783547000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/25\/3\/532\/5061966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,7,31]]},"published-print":{"date-parts":[[2019,2,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izy249","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,7,31]]}}}